We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$224B
AUM Growth
+$21B
Cap. Flow
+$7.48B
Cap. Flow %
3.33%
Top 10 Hldgs %
24.57%
Holding
10,190
New
1,427
Increased
4,227
Reduced
3,278
Closed
1,044

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$798M
2
T icon
AT&T
T
+$527M
3
MCHP icon
Microchip Technology
MCHP
+$472M
4
NFLX icon
Netflix
NFLX
+$446M
5
PNC icon
PNC Financial Services
PNC
+$444M

Top Sells

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$694M
2
KEY icon
KeyCorp
KEY
+$401M
3
DE icon
Deere & Co
DE
+$322M
4
CSX icon
CSX Corp
CSX
+$318M
5
NXPI icon
NXP Semiconductors
NXPI
+$314M

Sector Composition

Rank Sector Weight
1 Financials 5.93%
2 Technology 4.66%
3 Healthcare 4.45%
4 Industrials 4.14%
5 Consumer Discretionary 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
K
1951
PUT
DELISTED
Kellanova
K
$10.2M ﹤0.01%
155,277
-108,524
-41% -$7.31M
RSX
1952
CALL
DELISTED
VanEck Russia ETF
RSX
$10.2M ﹤0.01%
473,200
-181,700
-28% -$3.76M
BMRN icon
1953
PUT
BioMarin Pharmaceuticals
BMRN
$13B
$10.2M ﹤0.01%
105,100
+29,900
+40% +$2.98M
CLR
1954
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$10.2M ﹤0.01%
149,200
-53,000
-26% -$3.35M
VIPS icon
1955
PUT
Vipshop
VIPS
$6.81B
$10.2M ﹤0.01%
1,632,000
-1,929,600
-54% -$15.9M
ZGNX
1956
DELISTED
Zogenix, Inc.
ZGNX
$10.2M ﹤0.01%
205,133
+93,510
+84% +$4.76M
TYPE
1957
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$10.2M ﹤0.01%
502,939
+79,049
+19% +$1.63M
TUR icon
1958
PUT
iShares MSCI Turkey ETF
TUR
$222M
$10.1M ﹤0.01%
425,900
+280,600
+193% +$6.81M
GT icon
1959
CALL
Goodyear
GT
$1.76B
$10.1M ﹤0.01%
433,400
+105,900
+32% +$2.49M
VSH icon
1960
Vishay Intertechnology
VSH
$5.38B
$10.1M ﹤0.01%
498,112
-330,853
-40% -$7.79M
CCI icon
1961
CALL
Crown Castle
CCI
$32.3B
$10.1M ﹤0.01%
90,900
-21,200
-19% -$2.36M
VIAB
1962
CALL
DELISTED
Viacom Inc. Class B
VIAB
$10.1M ﹤0.01%
299,500
+128,200
+75% +$3.85M
AMED
1963
DELISTED
Amedisys
AMED
$10.1M ﹤0.01%
80,850
+39,292
+95% +$4.34M
XEC
1964
PUT
DELISTED
CIMAREX ENERGY CO
XEC
$10.1M ﹤0.01%
108,700
+56,900
+110% +$5.23M
WELL icon
1965
CALL
Welltower
WELL
$170B
$10.1M ﹤0.01%
156,500
-28,100
-15% -$1.82M
MYGN icon
1966
Myriad Genetics
MYGN
$290M
$10.1M ﹤0.01%
218,766
+137,291
+169% +$6.1M
WKC icon
1967
World Kinect Corp
WKC
$1.85B
$10.1M ﹤0.01%
363,227
-262,939
-42% -$6.75M
BG icon
1968
CALL
Bunge Global
BG
$21.8B
$10.1M ﹤0.01%
146,300
+7,400
+5% +$488K
J icon
1969
PUT
Jacobs Solutions
J
$16.9B
$10.1M ﹤0.01%
158,859
+53,195
+50% +$3.12M
NKTR icon
1970
PUT
Nektar Therapeutics
NKTR
$2.47B
$10M ﹤0.01%
10,987
-3,766
-26% -$3.21M
CMI icon
1971
Cummins
CMI
$86.9B
$10M ﹤0.01%
68,709
+9,200
+15% +$1.3M
ICE icon
1972
PUT
Intercontinental Exchange
ICE
$86.9B
$10M ﹤0.01%
134,000
+61,400
+85% +$4.62M
EMN icon
1973
CALL
Eastman Chemical
EMN
$8.47B
$10M ﹤0.01%
104,700
+33,100
+46% +$3.28M
NBL
1974
CALL
DELISTED
Noble Energy, Inc.
NBL
$10M ﹤0.01%
321,000
+238,600
+290% +$7.64M
CS
1975
PUT
DELISTED
Credit Suisse Group
CS
$10M ﹤0.01%
670,100
-16,600
-2% -$253K

Similar funds

Ken Griffin's Q3 2018 Portfolio in Review

As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.

By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.

  • Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
  • Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
  • Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
  • Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
  • Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
  • Ken Griffin opened 1,427 new positions and closed 1,044 in Q3 2018.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.

Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.